- May 06, 2021Source: Healthcare In Europe
The promise and reality about AI for interventional oncology
- April 16, 2019
Interventional Radiologists Perez Lozada and Marino Create First Endovascular Fistula in Connecticut
- March 14, 2019
New Treatment to Remove Clots Offers Dramatic Results
- February 18, 2019
Yale First in Connecticut to Offer Advanced Cardiac Test
- December 03, 2018
Yale Establishes Tanzania Interventional Radiology Initiative
Interventional Radiology
General Information
P.O. Box 208042, South Pavilion 2-213
New Haven, CT 06520-8042 Admin Assistant,Lori Raccio |
Phone:
Fax: |
203-785-4747
203-737-1077 |
Yale Interventional Radiology consists of a division of physicians specializing in the use of imaging modalities to guide the performance of minimally invasive diagnostic and therapeutic procedures in numerous parts of the body. Additionally, we are closely allied with Yale Vascular Surgery in a Yale Vascular Center, especially in the evaluation and treatment of arterial and venous blockages and aneurysms, including newer methods for angioplasty, the removal of material causing arterial blockage, and stent-grafts for aneurysms.
Clinical Interests
Other clinical interests include embolization for uterine fibroids, vascular anomalies, and pelvic congestion syndrome and varicoceles; minimally invasive treatment of cancer using embolization (including chemoembolization) and local treatments such as radiofrequency ablation; the management of varicose veins; interventions in bile ducts and the urinary track; and the placement of a variety of venous access devices.
Through the Yale Vascular Malformation Center, we are a world leader in the evaluation and treatment of patients with hereditary hemorrhagic telangiectasia (HHT, or Osler-Weber-Rendu syndrome).
Yale Interventional Radiologists see patients at our office in the Yale Physicians’ Building on Howard Avenue and perform procedures at Yale-New Haven Hospital and at the Veterans Administration Medical Center. In addition, we are active in training residents and fellows and conduct research.
Research Direction
- Outcome of embolotherapy for pulmonary arteriovenous malformations
- Transjugular intrahepatic portosystemic shunts
- Locoregional therapy for hepatocellular carcinoma
- Outcome after uterine fibroid embolization
- Carotid artery stenosis
- Thrombolytic spects and applications
- CT angiography of peripheral vascular disease
- Dynamic vascular imaging
- Clinical applications of phase contrast imaging
- Hemodialysis access catheters
- Endovascular surgery
- Stent technology
- Vascular imaging: improving vascular outcomes
- Fenestrated endografts; branched endografts
- Embolotherapy technics
- Vascular malformations
- Male infertility
- Pelvic congestion syndrome and fibroid disease
- Hereditary Hemorrhagic Telangiectasia
Yale Interventional Oncology Research Lab
Yale IR offers a unique research environment that encompasses the full gamut of basic, translational and clinical science, including clinical trials. Our NIH-funded science focuses on topics such as drug delivery, novel molecular targeted imaging and therapeutics, artificial intelligence and advanced intra-procedural navigation systems. We collaborate with partners in immunobiology, biomedical engineering and biophysics and have the most advanced experimental imaging equipment at our disposal, including a fully equipped state-of-the art Philips Allura Clarity C-Arm Interventional Suite. Our group has a track record of fostering careers of excellent IR trainees and junior faculty. Previous researchers and physician-scientists in IR won numerous national and international research prizes, such as the RSNA Trainee Prize, SIR Constantine Cope award, ECR Invest in Youth award and the prestigious PEO Foundation Award for Excellent Women in Science. Additional information can be found at the Yale Interventional Oncology Research Lab Website.
Education
Yale IR residency training in the Yale New Haven Medical Center program is the only IR training program in the state of Connecticut. Yale IR residency received continued accreditation from the ACGME in 2019. We offer three IR Internship-Residency positions per year. We are accepting IR Intern-Residency applications through ERAS/NRMP on a yearly basis. For more information about the Yale IR residency program, click here.
Yale IR Global Outreach
Yale IR is a leader in global IR, bringing minimally invasive treatment options to underserved populations worldwide. In collaboration with Emory University and Muhimbili University of Health and Allied Sciences, Yale IR has established the first accredited IR training program in sub-Saharan Africa. Before initiation of this training program there was not a single interventional radiologist in Tanzania, an East African nation with a population of nearly 60 million people. This means that many essential and life-saving procedures could not be performed. Yale IR has coordinated deployment of 14 teams to Tanzania for two-week teaching trips since 2018, overseeing more than 300 IR procedures ranging from simple biopsies to complex vascular procedures. Yale IR recognizes the important role minimally invasive treatments will play in improving medical care in Africa and is committed to making these advances available to as many people as possible. This work is supported by several institutional and national grants, including the RSNA Research & Education Foundation Derek Harwood-Nash International Scholar Grant. For more information visit Yale IR Outreach Program Website and @road2IR on Twitter, Facebook, and Instagram.
Twitter Feed
Recent Publications
2022
- Use of artificial intelligence in emergency radiology: An overview of current applications, challenges, and opportunities.Al-Dasuqi K, Johnson MH, Cavallo JJ. Clin Imaging. 2022 May 30; 2022 May 30. PMID: 35716432.
- PD-1 targeted immunotherapy for advanced hepatocellular carcinoma: current utilization and outcomes in the USA.Uhlig J, Stein S, Kim HS. Future Oncol. 2022 May; 2022 Feb 17. PMID: 35172633.
- 90Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study.Schaarschmidt BM, Wildgruber M, Kloeckner R, Nie J, Steinle V, Braat AJAT, Lohoefer F, Kim HS, Lahner H, Weber M, Theysohn J. J Nucl Med. 2022 May; 2021 Sep 2. PMID: 34475236.
- Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis.Wu X, Uhlig J, Blasberg JD, Gettinger SN, Suh RD, Solomon SB, Kim HS. J Vasc Interv Radiol. 2022 Apr 28; 2022 Apr 28. PMID: 35490932.
- Right heart thrombi (RHT) and clot in transit with concomitant PE management: Approach and considerations.Khosla A, Mojibian H, Assi R, Tantawy H, Singh I, Pollak J. Pulm Circ. 2022 Apr; 2022 Apr 25. PMID: 35514771.
- Cryoablation of Venous Malformations: A Systematic Review.Fish A, Moushey A, Chan SM, Staib L, Marino A, Schlachter T. J Vasc Interv Radiol. 2022 Apr 22; 2022 Apr 22. PMID: 35469956.
- Page kidney: an unusual complication of image-guided native renal parenchymal biopsy - case report and literature review.Rahman S, Imanzadeh A, Martin T, Ayyagari R. Radiol Case Rep. 2022 Jun; 2022 Apr 8. PMID: 35432668.
- Real-Time MRI-Guided Prostate Interventions.Masoom SN, Sundaram KM, Ghanouni P, Fütterer J, Oto A, Ayyagari R, Sprenkle P, Weinreb J, Arora S. Cancers (Basel). 2022 Apr 7; 2022 Apr 7. PMID: 35454773.
- Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.Llovet JM, Vogel A, Madoff DC, Finn RS, Ogasawara S, Ren Z, Mody K, Li JJ, Siegel AB, Dubrovsky L, Kudo M. Cardiovasc Intervent Radiol. 2022 Apr; 2022 Feb 4. PMID: 35119481.
- Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.Doemel LA, Santana JG, Savic LJ, Gaupp FML, Borde T, Petukhova-Greenstein A, Kucukkaya AS, Schobert IT, Hamm CA, Gebauer B, Walsh JJ, Rexha I, Hyder F, Lin M, Madoff DC, Schlachter T, Chapiro J, Coman D. Eur Radiol. 2022 Apr; 2021 Oct 31. PMID: 34718844.
- A rare presentation and management of thrombosis of an aberrant right subclavian artery related to thoracic outlet syndrome.Bellamkonda KS, Perez Lozada JC, Chaar CIO. Vascular. 2022 Apr; 2021 Apr 4. PMID: 33813970.
- Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.Berz AM, Santana JG, Iseke S, Gross M, Pekurovsky V, Laage Gaupp F, Savic LJ, Borde T, Gottwald LA, Boustani AM, Gebauer B, Lin M, Zhang X, Schlachter T, Madoff DC, Chapiro J. J Vasc Interv Radiol. 2022 Mar 26; 2022 Mar 26. PMID: 35346859.
- Machine Learning Applications for Differentiation of Glioma from Brain Metastasis-A Systematic Review.Jekel L, Brim WR, von Reppert M, Staib L, Cassinelli Petersen G, Merkaj S, Subramanian H, Zeevi T, Payabvash S, Bousabarah K, Lin M, Cui J, Brackett A, Mahajan A, Omuro A, Johnson MH, Chiang VL, Malhotra A, Scheffler B, Aboian MS. Cancers (Basel). 2022 Mar 8; 2022 Mar 8. PMID: 35326526.
- Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry.Toma C, Bunte MC, Cho KH, Jaber WA, Chambers J, Stegman B, Gondi S, Leung DA, Savin M, Khandhar S, Kado H, Koenig G, Weinberg M, Beasley RE, Roberts J, Angel W, Sarosi MG, Qaqi O, Veerina K, Brown MA, Pollak JS. Catheter Cardiovasc Interv. 2022 Mar; 2022 Feb 3. PMID: 35114059.
- Bronchial artery embolization for hemoptysis in a postpartum patient via cesarean section with COVID-19 while on extracorporeal membrane oxygenation.Lee M, Cornman-Homonoff J, Madoff DC. Clin Imaging. 2022 Mar; 2022 Jan 10. PMID: 35033849.